January 29, 2015
Otsuka Holdings said on January 28 that its bread-and-butter antipsychotic Abilify (aripiprazole) generated sales of US$4,931 million in the US and Puerto Rico in 2014, up 5.8% over the previous year. In October-December, sales leveled off at US$1,339 million, the...read more